Nanox Announces Multi-Segment Healthcare Collaboration with Monarch Medical Management to Expand Access to Advanced Medical Imaging
Nanox (NASDAQ:NNOX) has announced a strategic collaboration with Monarch Medical Management and Billing LLC to deploy advanced medical imaging solutions across multiple healthcare segments. The partnership will establish a comprehensive imaging network initially spanning over a dozen proof-of-concept sites, with plans for nationwide expansion.
The collaboration will integrate Nanox's technology, including the Nanox.ARC 3D digital tomosynthesis system, AI-powered software for CT scan analysis, and teleradiology services across workers' compensation facilities, nursing homes, and outpatient clinics. This initiative aims to improve access to advanced imaging services and accelerate diagnosis and treatment decisions.
Nanox (NASDAQ:NNOX) ha annunciato una collaborazione strategica con Monarch Medical Management and Billing LLC per implementare soluzioni avanzate di imaging medico in diversi segmenti sanitari. La partnership creerà una rete completa di imaging inizialmente in oltre una dozzina di siti pilota, con piani di espansione a livello nazionale. La collaborazione integrerà la tecnologia di Nanox, tra cui il sistema Nanox.ARC 3D digital tomosynthesis, software AI per l’analisi delle TAC e servizi di teleradiologia in strutture di indennizzo per lavoratori, case di cura e cliniche ambulatorie. Questa iniziativa punta a migliorare l’accesso a servizi di imaging avanzati e ad accelerare diagnosi e decisioni terapeutiche.
Nanox (NASDAQ:NNOX) ha anunciado una colaboración estratégica con Monarch Medical Management and Billing LLC para desplegar soluciones avanzadas de imagen médica en varios segmentos de la atención sanitaria. La asociación creará una red integral de imagen iniciando con más de una docena de sitios de prueba, con planes de expansión a nivel nacional. La colaboración integrará la tecnología de Nanox, incluyendo el sistema Nanox.ARC 3D tomosíntesis digital, software impulsado por IA para el análisis de TAC y servicios de teleradiología en instalaciones de compensación laboral, residencias y clínicas ambulatorias. Esta iniciativa busca mejorar el acceso a servicios de imagen avanzada y acelerar el diagnóstico y las decisiones de tratamiento.
Nanox (NASDAQ:NNOX)는 Monarch Medical Management and Billing LLC와 전략적 협력을 발표하여 여러 보건 의료 부문에 고급 의료 영상 솔루션을 배치합니다. 파트너십은 시험 운용 사이트 수십 곳을 초과하는 포괄적 영상 네트워크를 구축하고 전국적 확장을 계획합니다. 협력은 Nanox 기술을 통합하며, Nanox.ARC 3D 디지털 토모시스 시스템, CT 스캔 분석용 AI 소프트웨어, 노동자 보상 시설, 요양원 및 외래 진료 클리닉에서의 원격 방사 진료 서비스를 포함합니다. 이 이니셔티브의 목적은 선진 영상 서비스에 대한 접근성을 개선하고 진단 및 치료 의사결정을 가속화하는 것입니다.
Nanox (NASDAQ:NNOX) a annoncé une collaboration stratégique avec Monarch Medical Management and Billing LLC pour déployer des solutions d’imagerie médicale avancées dans plusieurs secteurs de la santé. Le partenariat créera un réseau d’imagerie complet débutant par plus d’une douzaine de sites pilotes, avec des plans d’expansion à l’échelle nationale. La collaboration intégrera la technologie Nanox, y compris le système Nanox.ARC 3D tomosynthèse numérique, un logiciel d’IA pour l’analyse des CT et des services de téléradiologie dans des établissements d’indemnisation des travailleurs, des maisons de retraite et des cliniques ambulatoires. Cette initiative vise à améliorer l’accès à des services d’imagerie avancés et à accélérer les décisions de diagnostic et de traitement.
Nanox (NASDAQ:NNOX) hat eine strategische Zusammenarbeit mit Monarch Medical Management and Billing LLC angekündigt, um fortschrittliche medizinische Bildgebungslösungen über mehrere Gesundheitssegmente hinweg einzuführen. Die Partnerschaft wird ein umfassendes Bildgebungsnetzwerk schaffen, zunächst über zwölf Proof-of-Concept-Standorte, mit Plänen zur landesweiten Expansion. Die Zusammenarbeit wird Nanox-Technologie integrieren, einschließlich des Nanox.ARC 3D Digital Tomosynthese-Systems, KI-gestützter Software zur CT-Analyse und Teleradiologie-Diensten in Arbeitsunfall-Einrichtungen, Pflegeheimen und ambulanten Kliniken. Ziel ist es, den Zugang zu fortschrittlicher Bildgebung zu verbessern und Diagnosen sowie Behandlungsentscheidungen zu beschleunigen.
Nanox (NASDAQ:NNOX) أعلنت عن تعاون استراتيجي مع Monarch Medical Management and Billing LLC لنشر حلول تصوير طبي متقدمة عبر عدة قطاعات صحية. ستنشئ الشراكة شبكة تصوير شاملة تبدأ بأكثر من اثني عشر موقعاً كنطاق إثبات المفاهيم، مع خطط للتوسع على مستوى البلاد. ستدمج الشراكة تكنولوجيا Nanox، بما في ذلك نظام Nanox.ARC 3D tomosynthesis الرقمي، وبرمجيات مدعومة بالذكاء الاصطناعي لتحليل فحص CT وخدمات التلي radiology في مرافق تعويض العمال، ودور الرعاية الصحية، وعيادات خارجية. تهدف هذه المبادرة إلى تحسين الوصول إلى خدمات التصوير المتقدمة وتسريع قرارات التشخيص والعلاج.
Nanox (NASDAQ:NNOX)宣布与 Monarch Medical Management and Billing LLC 建立战略合作，在多个医疗保健领域部署先进的医学影像解决方案。该伙伴关系将建立一个综合影像网络，初步覆盖 超过十几个概念验证站点，并计划全国扩展。合作将整合 Nanox 的技术，包括 Nanox.ARC 3D 数字断层成像系统、用于 CT 扫描分析的人工智能软件，以及在工伤赔付机构、养老院和门诊诊所中的远程放射服务。此举旨在改善获取前沿影像服务的机会，并加速诊断与治疗决策。
- Strategic expansion into multiple healthcare segments including workers' compensation, nursing homes, and outpatient clinics
- Partnership with established healthcare management organization with 30+ years of experience
- Planned nationwide expansion following initial proof-of-concept phase
- Integration of advanced AI-powered software and teleradiology services
- Initial deployment limited to dozen sites during proof-of-concept phase
- No financial terms or revenue projections disclosed
Insights
Nanox's collaboration with Monarch expands its imaging technology deployment across multiple healthcare segments, representing significant U.S. market penetration.
Nanox's newly announced collaboration with Monarch Medical Management marks a strategic expansion of its advanced imaging technology across diverse healthcare settings. The multi-segment approach targets three key markets: workers' compensation, nursing homes, and outpatient clinics—all areas where access to quick, high-quality imaging can significantly impact patient outcomes.
The deal's structure is particularly noteworthy. Beginning with a proof-of-concept phase across "over a dozen initial sites" provides Nanox a methodical entry pathway before the planned nationwide expansion. This phased approach helps mitigate implementation risks while establishing operational protocols.
For Nanox, this represents meaningful progress in their U.S. commercialization strategy for their Nanox.ARC system—a 3D digital tomosynthesis platform that differentiates from conventional X-ray technology. The deployment also includes their AI-powered diagnostic software and teleradiology services, creating an integrated imaging ecosystem rather than just hardware placement.
Monarch's 30+ years of healthcare management experience and established relationships across industry sectors provides Nanox with valuable distribution channels and operational support. This partnership model leverages Monarch's existing infrastructure and relationships, potentially accelerating adoption while minimizing direct sales and implementation costs for Nanox.
While financial terms weren't disclosed, this collaboration represents Nanox's continued execution on its business model of deploying its proprietary imaging technology across diverse healthcare settings, potentially creating recurring revenue streams through usage of both its hardware and AI-powered diagnostic tools.
Collaboration spans workers' compensation, nursing homes, and outpatient clinics
PETACH TIKVA, Israel, Sept. 18, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced a collaboration between its U.S. subsidiary Nanox Impact Inc. and Monarch Medical Management and Billing LLC (“Monarch”), an experienced healthcare management organization with established relationships across industry sectors, to deploy Nanox's advanced imaging solutions across multiple healthcare segments including workers' compensation, nursing home facilities, and outpatient clinics.
As part of the collaboration, Nanox will establish a comprehensive imaging network by deploying its technology across Monarch's associated healthcare facilities, including nursing homes, outpatient clinics, and dedicated imaging centers for workers' compensation cases. Monarch has identified over a dozen initial sites that will undergo a proof-of-concept phase, after which Nanox intends to expand the network nationwide.
The collaboration will provide patients across multiple care settings with access to advanced imaging services. Workers' compensation claimants, nursing home residents, outpatient clinic patients and others within Monarch's network will have access to Nanox’s end-to-end medical imaging solutions. These include the Nanox.ARC, an advanced 3D digital tomosynthesis imaging system; Nanox’s suite of AI-powered software that analyzes routine CT scans to identify early signs of chronic conditions; and teleradiology services.
“This collaboration addresses critical imaging access challenges across multiple healthcare segments by providing faster access to high-quality imaging services that can accelerate accurate diagnosis and treatment decisions for patients,” said Erez Meltzer, Chief Executive Officer and Acting Chairman of Nanox. “We look forward to working with Monarch as they provide management and consulting services to support our growing imaging network, representing another step in the U.S. expansion of the Nanox.ARC system.”
Nydia Soriano, CEO of Monarch, said, “The integration of Nanox’s advanced imaging technology is an exciting expansion of the comprehensive healthcare solutions that Monarch Medical Management has provided for more than 30 years. Nanox’s focus on early disease detection and preventive care aligns perfectly with our mission to deliver comprehensive care across our multi-segment healthcare settings. This collaboration will enhance patient outcomes across the diverse populations we serve.”
About Nanox
Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by bringing a full solution of affordable medical imaging technologies based on advanced AI and proprietary digital X-ray source.
Nanox's vision encompasses expanding the reach of Nanox technology both within and beyond hospital settings, providing a seamless end-to-end solution from scan to diagnosis, leveraging AI to enhance the efficiency of routine medical imaging technology and processes, in order to improve early detection and treatment and maintaining a clinically driven approach. The Nanox ecosystem includes Nanox.ARC – a multi-source digital tomosynthesis system that is cost-effective and user-friendly; Nanox.AI LTD – an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic diseases; Nanox.CLOUD – a cloud-based software platform that manages and stores data collected by Nanox devices, and provides users with tools for in-depth imaging analysis; Nanox.MARKETPLACE – a proprietary decentralized marketplace through Nanox’s subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts, and a comprehensive teleradiology services platform. By improving early detection and treatment, Nanox aims to enhance better health outcomes worldwide. For more information, please visit www.nanox.vision
Forward-Looking Statements
This press release may contain forward-looking statements that are subject to risks and uncertainties. All statements that are not historical facts contained in this press release are forward-looking statements. Such statements include, but are not limited to, any statements relating to the initiation, timing, progress and results of the Company’s research and development, manufacturing, and commercialization activities with respect to its X-ray source technology and the Nanox.ARC, the ability to realize the expected benefits of its recent acquisitions and the projected business prospects of the Company and the acquired companies. In some cases, you can identify forward-looking statements by terminology such as “can,” “might,” “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “should,” “could,” “expect,” “predict,” “potential,” or the negative of these terms or other similar expressions. Forward-looking statements are based on information the Company has when those statements are made or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Factors that could cause actual results to differ materially from those currently anticipated include: risks related to (i) Nanox’s ability to complete development of the Nanox System; (ii) Nanox’s ability to successfully demonstrate the feasibility of its technology for commercial applications; (iii) Nanox’s expectations regarding the necessity of, timing of filing for, and receipt and maintenance of, regulatory clearances or approvals regarding its technology, the Nanox.ARC and Nanox.CLOUD from regulatory agencies worldwide and its ongoing compliance with applicable quality standards and regulatory requirements; (iv) Nanox’s ability to realize the anticipated benefits of the acquisitions, which may be affected by, among other things, competition, brand recognition, the ability of the acquired companies to grow and manage growth profitably and retain their key employees; (v) Nanox’s ability to enter into and maintain commercially reasonable arrangements with third-party manufacturers and suppliers to manufacture the Nanox.ARC; (vi) the market acceptance of the Nanox System and the proposed pay-per-scan business model; (vii) Nanox’s expectations regarding collaborations with third-parties and their potential benefits; (viii) Nanox’s ability to conduct business globally; (ix) changes in global, political, economic, business, competitive, market and regulatory forces; (x) risks related to the current war between Israel and Hamas and any worsening of the situation in Israel; (xi) risks related to business interruptions resulting from the COVID-19 pandemic or similar public health crises, among other things; and (xii) potential litigation associated with our transactions.
For a discussion of other risks and uncertainties, and other important factors, any of which could cause Nanox’s actual results to differ from those contained in the Forward-Looking Statements, see the section titled “Risk Factors” in Nanox’s Annual Report on Form 20-F for the year ended December 31, 2024, and subsequent filings with the U.S. Securities and Exchange Commission. The reader should not place undue reliance on any forward-looking statements included in this press release. Except as required by law, Nanox undertakes no obligation to update publicly any forward-looking statements after the date of this press release to conform these statements to actual results or to changes in the Company’s expectations.
Contacts
Media Contact:
Ben Shannon
ICR Healthcare
NanoxPR@icrinc.com
Investor Contact:
Mike Cavanaugh
ICR Healthcare
mike.cavanaugh@icrhealthcare.com
FAQ
What is the partnership between Nanox (NNOX) and Monarch Medical Management?
What technology will Nanox (NNOX) deploy in this collaboration?
How many initial sites will be part of the Nanox-Monarch collaboration?
What healthcare segments will benefit from the Nanox-Monarch partnership?
Who is the CEO of Nanox (NNOX)?
